OKUR — Onkure Therapeutics Share News
0.000.00%
Last trade - 00:00- $102.05m
- -$74.34m
Brief: Reneo Pharmaceuticals Posts Q2 Loss Per Share $0.50
U.S. RESEARCH ROUNDUP-Capital City Bank Group, Independent Bank Group, Texas Instruments
Brief: Reneo Pharmaceuticals Reports Positive Results From Ren001 Long-Chain Fatty Acid Oxidation Disorders Study And Provides Additional Development Updates
Brief: Reneo Pharmaceuticals To Present Data From Phase 1 REN001 Limb Immobilization Study At The 17Th International Congress On Neuromuscular Diseases (ICNMD 2022)
U.S. RESEARCH ROUNDUP-Aerovironment, Koninklijke Ahold Delhaize NV, Walmart
Brief: Reneo Pharmaceuticals Inc Files For Mixed Shelf Of Up To $200 Million - SEC Filing
U.S. RESEARCH ROUNDUP- Agrify, Okta, Schnitzer Steel Industries
Brief: Reneo Pharmaceuticals Reports Fourth Quarter 2021 Financial Results
Brief: Reneo Pharmaceuticals Appoints Michael Cruse Chief Operating Officer
Brief: Reneo Pharmaceuticals Inc - On January 28 Vineet Jindal Notified Of His Intention To Resign As CFO Effective As Of March 31
Brief: Reneo Announces Changes To Board Of Directors
Brief: Reneo Pharmaceuticals Posts Q3 Loss Per Share Of $0.52
Brief: Reneo Pharmaceuticals Inc Announces Notice Of Allowance For Patent Application On REN001
NASDAQ RESUMED AT 09:46 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:41 AM
Reneo Pharmaceuticals Inc reports results for the quarter ended in June - Earnings Summary
Brief: Reneo Pharmaceuticals Says First Patient Has Been Dosed In Stride Study
Reneo Pharmaceuticals: Rises after director buys stake
Brief: Reneo Pharmaceuticals Q1 Loss Per Share $3.48